» Articles » PMID: 34946054

Clinical and Functional Predictors of Response to a Comprehensive Pulmonary Rehabilitation in Severe Post-COVID-19 Patients

Overview
Journal Microorganisms
Specialty Microbiology
Date 2021 Dec 24
PMID 34946054
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pulmonary rehabilitation (PR) following severe and very severe COVID-19 infection is known to be effective, according to typical assessments. However, not all patients benefit from PR to the same extent. This analysis aimed to identify the impact of different factors on PR outcomes in post-COVID-19 patients.

Methods: This prospective observational study included 184 post-COVID-19 patients. The achievement of the predicted reference walking distance (6 min walking distance (6-MWD)) served as a parameter with which to identify responders and non-responders to PR. Several parameters (e.g., Functional Independent Measurement (FIM); pulmonary function testing (Forced Vital Capacity, FVC); 6MWD) were assessed in order to estimate their impact on PR success. Logistic regression models and classification and regression trees were used for multivariate analysis.

Results: A total of 94 patients (51%) reached their reference 6MWD by the end of PR. FVC (0.95 (0.93-0.97)), 6MWD at admission (0.99 (0.99-1.00)), and FIM motoric (0.96 (0.93-0.99)) correlated with the risk not reaching the reference distance. The most important variable was the 6MWD at admission. Classification and regression tree identified 6MWD ≥ 130 m at admission and FVC predicted of >83% as the strongest predictor for reaching predicted 6-MWD.

Conclusion: Post-COVID-19 patients with lower 6MWD, lower motoric FIM scores and lower FVC at admission have a high risk of not reaching their target values of physical performance despite intensive rehabilitation. As well as identifying them, it is of utmost importance to develop optimal PR concepts for these patients.

Citing Articles

Post-Severe-COVID-19 Cardiopulmonary Rehabilitation: A Comprehensive Study on Patient Features and Recovery Dynamics in Correlation with Workout Intensity.

Dumitrescu A, Doros G, Lazureanu V, Septimiu-Radu S, Bratosin F, Rosca O J Clin Med. 2023; 12(13).

PMID: 37445425 PMC: 10342827. DOI: 10.3390/jcm12134390.


SARS-CoV-2 Systemic Effects: New Clues.

Beltrami S, Rizzo S, Caccuri F, Rizzo R, Bortolotti D, Schiuma G Microorganisms. 2023; 11(5).

PMID: 37317183 PMC: 10221368. DOI: 10.3390/microorganisms11051209.


Effects of Physiotherapy on Rehabilitation and Quality of Life in Patients Hospitalized for COVID-19: A Review of Findings from Key Studies Published 2020-2022.

Beqaj S, Macak Hadziomerovic A, Pasalic A, Jaganjac A Med Sci Monit. 2022; 28:e938141.

PMID: 36221250 PMC: 9575512. DOI: 10.12659/MSM.938141.


Rehabilitation and COVID-19: update of the rapid living systematic review by Cochrane Rehabilitation Field as of December 31st, 2021.

Negrini F, de Sire A, Andrenelli E, Lazzarini S, Patrini M, Ceravolo M Eur J Phys Rehabil Med. 2022; 58(2):328-331.

PMID: 35244366 PMC: 9980523. DOI: 10.23736/S1973-9087.22.07497-4.

References
1.
Bertolucci F, Sagliocco L, Tolaini M, Posteraro F . Comprehensive rehabilitation treatment for sub-acute COVID-19 patients: an observational study. Eur J Phys Rehabil Med. 2021; 57(2):208-215. DOI: 10.23736/S1973-9087.21.06674-0. View

2.
Davis M, Walsh B, Sittig S, Restrepo R . AARC clinical practice guideline: blood gas analysis and hemoximetry: 2013. Respir Care. 2013; 58(10):1694-703. DOI: 10.4187/respcare.02786. View

3.
Qin W, Chen S, Zhang Y, Dong F, Zhang Z, Hu B . Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up. Eur Respir J. 2021; 58(1). PMC: 7877322. DOI: 10.1183/13993003.03677-2020. View

4.
. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166(1):111-7. DOI: 10.1164/ajrccm.166.1.at1102. View

5.
Spruit M, Holland A, Singh S, Tonia T, Wilson K, Troosters T . COVID-19: interim guidance on rehabilitation in the hospital and post-hospital phase from a European Respiratory Society- and American Thoracic Society-coordinated international task force. Eur Respir J. 2020; 56(6. PMC: 7427118. DOI: 10.1183/13993003.02197-2020. View